tradingkey.logo
搜索

Clene Inc.

CLNNW
添加自选
0.002USD
0.0000.00%
收盘 美东报价延迟15分钟
0.00总市值
--市盈率 TTM

关于 Clene Inc. 公司

Clene Inc. 是一家后期临床阶段的生物制药公司,专注于改善线粒体健康和保护神经元功能,以治疗神经退行性疾病,包括肌萎缩侧索硬化症、帕金森病和多发性硬化症。该公司专门从事新型清洁表面纳米技术 (CSN) 疗法的发现、开发和商业化。其 CNM-Au8 是一种研究性一流疗法,通过针对线粒体功能和烟酰胺腺嘌呤二核苷酸途径的机制改善中枢神经系统细胞的存活和功能,同时减少氧化应激。其 CNM-ZnAg 是一种广谱抗病毒抗菌剂,由锌 (Zn2+) 和银 (Ag+) 离子组成,正在开发用于治疗传染病并为症状缓解提供免疫支持。其 CNM-AgZn17 是一种 Zn2+ 和 Ag+ 的凝胶聚合物悬浮液,正在开发用于治疗传染病和支持伤口愈合。

Clene Inc.简介

公司代码CLNNW
公司名称Clene Inc.
上市日期Aug 27, 2018
CEOMr. Robert Etherington
员工数量- -
证券类型Company Warrant
年结日- -
公司地址6550 South Millrock Drive, Suite G50
城市SALT LAKE CITY
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编84121
电话18016769695
网址https://clene.com/
公司代码CLNNW
上市日期Aug 27, 2018
CEOMr. Robert Etherington

Clene Inc.公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Shalom Jacobovitz
Mr. Shalom Jacobovitz
Independent Director
Independent Director
--
--
Mr. David J. Matlin
Mr. David J. Matlin
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Jonathon T. Gay
Mr. Jonathon T. Gay
Independent Director
Independent Director
--
--
Mr. Mark Mortenson
Mr. Mark Mortenson
Co-Founder, Chief Science Officer
Co-Founder, Chief Science Officer
--
--
Mr. Reed Neil Wilcox
Mr. Reed Neil Wilcox
Independent Director
Independent Director
--
--
Mr. Robert Etherington
Mr. Robert Etherington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Vallerie V. Mclaughlin, M.D.
Dr. Vallerie V. Mclaughlin, M.D.
Independent Director
Independent Director
--
--
Mr. Morgan R. Brown
Mr. Morgan R. Brown
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Alison H. Mosca
Ms. Alison H. Mosca
Independent Director
Independent Director
--
--
Prof. Matthew Kiernan, Ph.D.
Prof. Matthew Kiernan, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Shalom Jacobovitz
Mr. Shalom Jacobovitz
Independent Director
Independent Director
--
--
Mr. David J. Matlin
Mr. David J. Matlin
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Jonathon T. Gay
Mr. Jonathon T. Gay
Independent Director
Independent Director
--
--
Mr. Mark Mortenson
Mr. Mark Mortenson
Co-Founder, Chief Science Officer
Co-Founder, Chief Science Officer
--
--
Mr. Reed Neil Wilcox
Mr. Reed Neil Wilcox
Independent Director
Independent Director
--
--
Mr. Robert Etherington
Mr. Robert Etherington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--